BUSINESS BRIEFING
- Share via
Times Wire Reports
The Alabama Supreme Court threw out jury decisions awarding the state more than $274 million from three pharmaceutical companies, ruling that they did not defraud the state in pricing Medicaid prescription drugs.
The court rescinded verdicts against AstraZeneca, Novartis and GlaxoSmithKline, which were accused by the state of fraudulently manipulating prices of drugs for Medicaid recipients.
